1. Takeda S, et al. Cannabidiolic acid as a selective cyclooxygenase-2 inhibitory component in cannabis. Drug Metab Dispos. 2008;36(9):1917-21. PMID: 18556441
2. Bolognini D, et al. Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation. Br J Pharmacol. 2013;168(6):1456-70. PMID: 23121618
3. Vigli D, et al. Chronic Treatment with Cannabidiolic Acid (CBDA) Reduces Thermal Pain Sensitivity in Male Mice. Neuroscience. 2021;453:113-123. PMID: 33010341
4. Takeda S, et al. Down-regulation of cyclooxygenase-2 (COX-2) by cannabidiolic acid in human breast cancer cells. J Toxicol Sci. 2014;39(5):711-6. PMID: 25242400
5. Ruhaak LR, et al. Evaluation of the cyclooxygenase inhibiting effects of six major cannabinoids. Biol Pharm Bull. 2011;34(5):774-8. PMID: 21532172
6. Formato M, et al. (-)-Cannabidiolic Acid, a Still Overlooked Bioactive Compound. Molecules. 2020;25(11):2638. PMID: 32503116
7. De Gregorio D, et al. Cannabidiol modulates serotonergic transmission and reverses allodynia and anxiety-like behavior. Pain. 2019;160(1):136-150. PMID: 30157131
8. Rock EM, et al. Effect of low doses of cannabidiolic acid and ondansetron on LiCl-induced conditioned gaping. Br J Pharmacol. 2013;169(3):685-92. PMID: 23488964
9. Pertwee RG, et al. Cannabidiolic acid methyl ester produces 5-HT1A receptor-mediated suppression of nausea and anxiety. Br J Pharmacol. 2018;175(1):100-112. PMID: 29044616
10. Resstel LBM, et al. 5-HT1A receptors are involved in cannabidiol-induced attenuation of stress responses. Br J Pharmacol. 2009;156(1):181-8. PMID: 19133999
11. Costa B, et al. Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of cannabidiol in acute inflammation. Br J Pharmacol. 2004;143(2):247-50. PMID: 15313881
12. Starkus J, et al. Diverse TRPV1 responses to cannabinoids. Channels (Austin). 2019;13(1):172-191. PMID: 31088309
13. Wakshlag JJ, et al. Pharmacokinetics of Cannabidiol, Cannabidiolic Acid and Related Metabolites. Front Vet Sci. 2020;7:505. PMID: 33102539
14. Anderson LL, et al. Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid. J Nat Prod. 2019. doi: 10.1021/acs.jnatprod.9b00600
15. Goerl B, et al. Cannabidiolic acid exhibits entourage-like improvements of anticonvulsant activity. Epilepsy Res. 2021;169:106525. PMID: 33310415
16. Rock EM, et al. Evaluation of CBD, CBDA or CBDA methyl ester on nausea and vomiting. Psychopharmacology. 2020;237(9):2621-2631. PMID: 32488349
17. Aragona F, et al. Role of cannabidiolic acid in pain modulation in horses with chronic osteoarthritis. Front Vet Sci. 2024;11:1496473. PMID: 39720409
18. Kleinhenz MD, et al. Industrial hemp with high CBDA increases lying behavior and reduces stress biomarkers. Sci Rep. 2022;12(1):3683. PMID: 35256692
19. Rock EM, et al. Therapeutic potential of cannabidiol, cannabidiolic acid, and CBDA methyl ester for nausea and vomiting. Cannabis Cannabinoid Res. 2021. doi: 10.1089/can.2021.0041
20. Perucca E, Bialer M. Critical aspects affecting cannabidiol oral bioavailability and metabolic elimination. CNS Drugs. 2020. PMID: 32504402